Detalhe da pesquisa
1.
Survival with Cemiplimab in Recurrent Cervical Cancer.
N Engl J Med
; 386(6): 544-555, 2022 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139273
2.
Cervical cancer kills 300,000 people a year - here's how to speed up its elimination.
Nature
; 626(7997): 30-32, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291141
3.
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
N Engl J Med
; 385(20): 1856-1867, 2021 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534429
4.
[18F]FDG-PET/CT-based risk stratification in women with locally advanced uterine cervical cancer.
BMC Cancer
; 24(1): 513, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38654241
5.
A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy.
Mol Cell
; 63(3): 514-25, 2016 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27453043
6.
MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: a subgroup analysis of a phase II prospective trial.
Int J Clin Oncol
; 29(5): 620-628, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38530569
7.
The intersection of race/ethnicity and socioeconomic status: inequalities in breast and cervical cancer mortality in 20,665,005 adult women from the 100 Million Brazilian Cohort.
Ethn Health
; 29(1): 46-61, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37642313
8.
[Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
Zhonghua Fu Chan Ke Za Zhi
; 59(4): 307-319, 2024 Apr 25.
Artigo
em Zh
| MEDLINE | ID: mdl-38644277
9.
Survival differences by race and surgical approach in early-stage operable cervical Cancer.
Gynecol Oncol
; 179: 63-69, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37926048
10.
Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study.
Gynecol Oncol
; 171: 141-150, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898292
11.
Differences in Cervical Cancer Outcomes by Caribbean Nativity in Black and White Women in Florida.
Cancer Control
; 30: 10732748231176642, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226430
12.
Programmed death-ligand 1 expression in human papillomavirus-independent cervical adenocarcinoma and its prognostic significance.
Histopathology
; 80(2): 338-347, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34455625
13.
Construction and validation of the prognostic model for patients with neuroendocrine cervical carcinoma: a competing risk nomogram analysis.
BMC Cancer
; 22(1): 4, 2022 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34980030
14.
Developing a 5-gene prognostic signature for cervical cancer by integrating mRNA and copy number variations.
BMC Cancer
; 22(1): 192, 2022 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35184747
15.
The role of Tim-3/Galectin-9 pathway in T-cell function and prognosis of patients with human papilloma virus-associated cervical carcinoma.
FASEB J
; 35(3): e21401, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33559190
16.
Overall survival in patients with FIGO stage IVA cervical cancer.
Gynecol Oncol
; 166(2): 292-299, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35691754
17.
Long-term oncological safety of sentinel lymph node biopsy in early-stage cervical cancer: A post-hoc analysis of SENTICOL I and SENTICOL II cohorts.
Gynecol Oncol
; 164(1): 53-61, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34696894
18.
Global distribution, risk factors, and recent trends for cervical cancer: A worldwide country-level analysis.
Gynecol Oncol
; 164(1): 85-92, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34799136
19.
Predicting the risk of the distant recurrence of cervical cancer after concurrent chemoradiation: A validation study of the Korean Gynecologic Oncologic Group (KGOG)-1024 model.
Gynecol Oncol
; 164(1): 62-67, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34696893
20.
Post-recurrence survival in patients with cervical cancer.
Gynecol Oncol
; 164(2): 362-369, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34955236